Camp4 Therapeutics Corporation
CAMP
$3.25
-$0.06-1.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.98% | -0.09% | 0.15% | -2.22% | -15.30% |
| Total Depreciation and Amortization | -0.48% | 1.42% | -3.44% | -3.91% | -2.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 85.98% | 11.77% | 12.52% | 17.71% | 83.29% |
| Change in Net Operating Assets | -128.15% | 116.94% | -800.97% | 195.19% | -63.44% |
| Cash from Operations | -15.72% | 23.03% | -28.21% | 4.20% | -47.89% |
| Capital Expenditure | -- | 100.00% | -1,760.00% | -8.23% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -1,760.00% | -8.23% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 45.85% | 135.29% | 25.98% | 10.59% | -0.49% |
| Issuance of Common Stock | 104,948.39% | -- | -- | 44,080.92% | 3,000.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7,142.45% | -- | -- | -- | -- |
| Cash from Financing | 12,375.65% | 108.87% | 25.25% | 116,071.43% | -90.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 459.19% | 28.74% | -29.54% | 608.82% | -44.73% |